What Mounjaro does to your skin — and what it doesn't

The myth: Mounjaro is unusually harsh on skin

One of the most common misconceptions our prescribers hear is that tirzepatide causes widespread, persistent skin problems. It doesn't, at least not for most people. The licensed prescribing information (verified on the Mounjaro SmPC on the eMC) lists injection-site reactions as a common side effect, meaning they occur in roughly one in ten or more users. These are localised: a patch of redness, some mild swelling, or a small bruise around where the pen was pressed. They're the immune system noticing a subcutaneous injection, and they generally clear within 48 hours.

What makes them worse? Using the same spot each week. Rotating between your abdomen, thigh and upper arm (and moving a few centimetres from the previous site within each area) reduces the likelihood of a reaction building up. It's one of the things worth reading carefully in the Patient Information Leaflet that comes with each pen.

Persistent redness, hardened skin at the site, or any sign of infection (warmth, pus, worsening pain) should be reviewed by your prescriber or GP rather than managed with over-the-counter cream and patience. The sore skin at the injection site page goes into more practical detail on technique and what to watch for.

Dry and itchy skin: what's actually driving it

Some people notice their skin feels drier in the first months of treatment. This is rarely a direct pharmacological effect of tirzepatide itself. The more plausible explanation is indirect: tirzepatide is highly effective at reducing appetite and slowing gastric emptying, which means people often eat and drink noticeably less without realising it. Mild dehydration affects skin turnover. Reduced intake of healthy fats, vitamins A, C and E, and zinc (all found in foods many people eat less of when appetite falls) can also affect skin texture and healing.

The practical response is straightforward: keep fluid intake up, prioritise protein and vegetables alongside the calorie reduction, and use a good moisturiser if dryness is uncomfortable. If your skin feels unusually dry or tight, it's worth flagging at your next clinical review rather than assuming it's unavoidable. Our overview of how tirzepatide affects the skin explains the wider picture, including which nutrients to watch for on a reduced-calorie eating pattern. The guide to dryness on Mounjaro covers this in more depth, including which nutrients to watch for on a reduced-calorie eating pattern.

The NHS tirzepatide page lists the recognised side effects and is a reliable first reference if you're unsure whether something you're noticing has been reported in clinical data.

Loose skin after weight loss: what Mounjaro can and can't control

Tirzepatide's clinical results are significant. In the SURMOUNT-1 trial, involving thousands of adults with obesity, average weight loss at the highest dose was around 20–21% of starting body weight over 72 weeks. Losing that much weight relatively quickly (compared with, say, years of gradual dieting) means the skin has less time to contract as the tissue beneath it reduces. The result, for some people, is loose or sagging skin, particularly around the abdomen, upper arms and thighs.

This isn't a side effect of the medicine specifically. It's a consequence of substantial weight loss by any method. Age plays a significant role, skin elasticity decreases naturally from the mid-thirties onwards. Genetics, how much weight is lost in total, and whether resistance exercise is maintained all affect the outcome. Slower loss doesn't entirely prevent it; some laxity is normal after large losses.

There's no medicine or cream that reverses significantly loose skin. Strength training throughout the weight-loss period can help by preserving muscle mass and giving the skin a firmer underlying structure. For people concerned about this before starting treatment, it's worth raising during the consultation. The loose skin and Mounjaro page has a fuller discussion of what the evidence supports.

Rashes not at the injection site: when to pay attention

A rash away from where you injected deserves a closer look. Allergic reactions to tirzepatide are uncommon but documented; signs include an itchy, spreading rash, swelling (particularly of the face, lips or throat), or difficulty breathing. These require prompt medical attention, not a wait-and-see approach. Stop using the pen and contact a healthcare professional.

More often, a mild rash elsewhere on the body during Mounjaro treatment has a mundane cause, a new washing powder, a change in diet, skin reacting to being drier than usual. But the important point is not to assume it's nothing, particularly if it appears in the first few weeks of treatment or after a dose increase. Report unexpected skin changes to your prescriber; that's part of what clinical review is for. You can explore known skin reactions in more detail on the Mounjaro rash page.

If you're considering treatment and want to understand how it's prescribed, the tirzepatide overview covers the clinical framework, and the weight-loss treatments page explains how a consultation with our prescribers works. Every prescription at nume is personally reviewed (not processed by a system) before anything is dispensed. Your pen arrives in plain packaging the next working day, tracked via DPD, with no indication of what's inside.